Archived explainer. For the current picture see today's AGL page.
Why Is AGILON HEALTH INC (AGL) Stock Down Today?
AGILON HEALTH INC (AGL) is down -21.41% in the latest session. Our newswire has captured 3 stories on AGL across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100).
Agilon Health Inc (AGL) shares fell 21.41% to $90.53, driven by a sharp reversal in analyst sentiment and technical breakdowns. The decline occurred despite recent price target increases from Bernstein, highlighting a disconnect between institutional ratings and market reality.
What Happened
The stock’s drop coincided with a mixed landscape of analyst actions. Bernstein raised its price target to $138 from $125 while maintaining an Outperform rating. Conversely, Truist reiterated a Hold rating with a $112 price target. This divergence in coverage, spanning multiple firms, failed to support the share price.
External context indicates further pressure from other institutions. Deutsche Bank trimmed its price target to $132 from $139, following an earlier adjustment to $139. Wells Fargo maintained an Overweight rating, while Evercore ISI Group also raised its price target. Despite these varied views, the market reaction was decisively negative. Agilon Health is scheduled to host a virtual investor event on November 17, 2026, which may provide further clarity on operational performance.
What The Data Shows
The session’s technical profile underscores the severity of the sell-off. On November 18, 2026, the stock printed 39 fresh 52-week lows, signaling a significant breakdown in price support. The 52-week range spans from $7.48 to $133.04, placing the current price near the lower end of its historical band.
Fundamental metrics reveal ongoing challenges for the company. Agilon Health remains unprofitable with a trailing twelve-month EPS of -$6.37 and a net margin of -1.5%. Revenue growth was limited to 2.0% over the same period. The company’s market capitalization stands at $1.9 billion. With a beta of 3.11, the stock exhibits high volatility relative to the broader market, amplifying the impact of negative news or sentiment shifts.
What To Watch
Investors will monitor the upcoming virtual investor event on November 17, 2026, for updates on strategic direction and financial health. The breadth of analyst coverage, including recent target adjustments from Bernstein, Truist, Deutsche Bank, Wells Fargo, and Evercore ISI Group, remains a key area for observation as the company navigates its current valuation and profitability challenges.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
AGL by the numbers
The headlines behind the move
Agilon Health Price Target Raised To 138 From 125 At Bernstein
Truist reiterates agilon health stock Hold rating at $112 target
Truist reiterates agilon health stock Hold rating at $112 target
More on AGL: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier AGL move explainers: 2026-11-19 · 2026-11-18